Central Pacific Bank - Trust Division’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,805
Closed -$126K – 898
2026
Q2
$126K Buy
1,805
+5
+0.3% +$259 0.01% 561
2026
Q1
$91.4K Buy
+1,800
New +$84K 0.01% 593

Other funds holding MRNA

Central Pacific Bank - Trust Division's MRNA Position: Q3 2026 in Review

Central Pacific Bank - Trust Division sold out of Moderna (MRNA) in Q3 2026, closing a stake of 1,805 shares — an estimated $126K sold.

Central Pacific Bank - Trust Division first reported a position in MRNA in Q1 2026 and held it in 2 quarters. The position peaked at $126K in Q2 2026. 31 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Central Pacific Bank - Trust Division reported no remaining Moderna position as of Q3 2026 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 1,805 Moderna shares in Q3 2026, an estimated $126K.
  • Central Pacific Bank - Trust Division first reported a position in Moderna in Q1 2026 and held it in 2 quarters.
  • Central Pacific Bank - Trust Division's Moderna position peaked at $126K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.